(Q51473059)

English

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

type 2 diabetes

1 reference

based on heuristic

inferred from title

Shohreh Khatami

object named as

Shohreh Khatami

5

0 references

Bagher Larijani

3

object named as

Bagher Larijani

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

author name string

Reza Meshkani

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Mohammad Taghikhani

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Yadollah Bahrami

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Ehteram Khoshbin

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Amir Ghaemi

7

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Sedigheh Sadeghi

8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Fatemeh Mirkhani

9

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Azam Molapour

10

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Khosrow Adeli

11

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

45

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

477-482

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

Insulin resistance as the core defect in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Sample size requirements for matched case-control studies of gene-environment interaction

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Impact of associated conditions on glycemic control of NIDDM patients

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The Pro12Ala polymorphism of PPARγ2 gene and susceptibility to type 2 diabetes mellitus in a Polish population

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.095

21 January 2018

Identifiers

10.1515/CCLM.2007.095

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

release_bgmioujbbnharkxqkip4g25dbi

1 reference

https://api.fatcat.wiki/v0/release/bgmioujbbnharkxqkip4g25dbi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17439324

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51473059&oldid=2161357590"